PANXEON reads three signals to catch pancreatic cancer sooner
An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…
Editor's Top Picks
One AI watchdog now covers every ward in Abu Dhabi
A year after launch, the emirate's health department says its AI patient safety platform now connects 100% of hospitals and…
Your one-stop resource for medical news and education.
Altis Labs banks $25M as its imaging endpoint beats RECIST
The Toronto company raised a Series A co-led by OrbiMed and Qiming Venture Partners USA for AI that reads trial…
FDA backs LLM juries to grade AI-written radiology reports
A $1.29M FDA contract will test whether several language models, supervised by radiologists, can evaluate AI-generated reports across roughly a…
Mithrl raises $20M for a biomedical world model aimed at R&D
The company says its platform can cut the time from a research idea to an investigational new drug filing by…
Voice AI mispronounces one in three new drug names, benchmark finds
A new benchmark finds commercial text-to-speech models mispronounce recently approved medicines far more often than familiar ones.
Novo Nordisk puts Claude Science to work on stubborn research problems
The Danish drugmaker will test Anthropic's Claude Science models against research questions it has so far failed to crack.
Anew Labs leaves ByteDance with $290M to design drugs with AI
The Shanghai spinout's first outside round values the young company near $1.5B and keeps ByteDance as its largest shareholder.
Bill Gates bets $1B that AI can narrow the global health gap
The pledge, tied to the foundation's 2026 Goalkeepers report, will fund partners building AI health tools with the people who…
Penn Medicine hands 10,000 clinicians an AI second opinion
OpenEvidence will reach about 10,000 clinicians across seven hospitals, and the same tool goes to Penn's partnership in Botswana.